In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment

The live attenuated mycobacterial strain BCG, in use as vaccine against tuberculosis, is considered the gold standard for primary therapy of carcinoma in situ of the bladder. Despite its limitations, to date it has not been surpassed by any other treatment. Our group has developed a recombinant BCG...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Dunia, Goulart, Cibelly, Pagliarone, Ana C., Silva, Eliane P., Cunegundes, Priscila S., Nascimento, Ivan P., Borra, Ricardo C., Dias, Waldely O., Tagliabue, Aldo, Boraschi, Diana, Leite, Luciana C. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607967/
https://www.ncbi.nlm.nih.gov/pubmed/31297119
http://dx.doi.org/10.3389/fimmu.2019.01460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607967/
https://www.ncbi.nlm.nih.gov/pubmed/31297119
http://dx.doi.org/10.3389/fimmu.2019.01460

Ejemplares similares